Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

January 2015

Specialty Pharmacy Program Updates 


Harvard Pilgrim’s Specialty Pharmacy Program has added the following medications for both the Premium and Value formularies.

Name Indication Coverage Available From

Otezla   (apremilast) 

Otezla, an inhibitor of phosphodiesterase 4 (PDE4), is indicated for the treatment of adult patients with active psoriatic arthritis or with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.  Pharmacy Benefit  Accredo

Harvard Pilgrim’s Specialty Pharmacy Program has added the following medications for the Premium formulary only.

Name Indication Coverage Available From

Esbriet (pirfenidone)

Esbriet is a pyridone indicated for the treatment of idiopathic pulmonary fibrosis (IPF). Pharmacy Benefit  Accredo

Hetlioz (tasimelteon) 

Hetlioz is a melatonin receptor agonist indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24).  Pharmacy Benefit  Accredo

Plegridy (peginterferon beta-1a) 

Plegridy is an interferon beta indicated for the treatment of patients with relapsing forms of multiple sclerosis.  Pharmacy Benefit  Accredo

Email this article to a colleague   


Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

Reminder: New Version of CAQH Coming in February

Health Plans Acquires TrestleTree for Wellness Management

CLINICIAN CORNER

Appropriate Coding for Monovisc

Quantity Limits on Extended-Release Morphine Medications

Coverage for Diagnostic Ultrasound Exams

Payment policy updates: Radiology

Diagnosis Coding for HEDIS and Risk Adjustment

Identifying and Treating Seasonal Affective Disorder

P&T Committee Updates

Specialty Pharmacy Program Updates

OFFICE ASSISTANT

2015 Fee Schedule Updates

HPHConnect Account Management for Inactive Users

Reminder: Ensure That Claims Contain Valid Codes

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,
Editor

Joseph O'Riordan,
Contributing Writer

Kristin Edmonston,
Production Coordinator